Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 9/20 | 0.57 |
| ▸ | BACE1 | P56817 | 6/20 | 0.47 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.46 |
| ▸ | CTSD | P07339 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.45 |
| ▸ | BMP1 | P13497 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30659898 | 1.00 | FOLH1 (0.57) | FOLH1BACE1NAALAD2CTSDPTPN1 | |
| SCHEMBL29679534 | 0.96 | FOLH1 (0.56) | FOLH1BACE1NAALAD2CTSDPTPN1 | |
| SCHEMBL29679903 | 0.96 | FOLH1 (0.55) | FOLH1BACE1NAALAD2CTSDPTPN1 | |
| SCHEMBL1674769 | 0.96 | FOLH1 (0.50) | FOLH1BACE1 | |
| SCHEMBL1674773 | 0.95 | FOLH1 (0.63) | FOLH1BACE1NAALAD2PTPN1 | |
| SCHEMBL31454946 | 0.93 | FOLH1 (0.61) | FOLH1BACE1NAALAD2CTSD | |
| SCHEMBL30553676 | 0.93 | FOLH1 (0.61) | FOLH1BACE1NAALAD2CTSD | |
| SCHEMBL29846196 | 0.93 | FOLH1 (0.61) | FOLH1BACE1NAALAD2CTSD | |
| SCHEMBL30596286 | 0.92 | BACE1 (0.52) | FOLH1BACE1CTSDBMP1 | |
| SCHEMBL30903465 | 0.92 | FOLH1 (0.49) | FOLH1BACE1CTSDBMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |